239 related articles for article (PubMed ID: 10855949)
1. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
Liu XX; Wilson K; Charlton CG
Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
[TBL] [Abstract][Full Text] [Related]
2. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
3. The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.
Benson R; Crowell B; Hill B; Doonquah K; Charlton C
Neurochem Res; 1993 Mar; 18(3):325-30. PubMed ID: 8479601
[TBL] [Abstract][Full Text] [Related]
4. Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats.
Miller JW; Shukitt-Hale B; Villalobos-Molina R; Nadeau MR; Selhub J; Joseph JA
Clin Neuropharmacol; 1997 Feb; 20(1):55-66. PubMed ID: 9037574
[TBL] [Abstract][Full Text] [Related]
5. On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain.
Waldmeier PC; Feldtrauer JJ
Biochem Pharmacol; 1987 Sep; 36(17):2855-61. PubMed ID: 3632711
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.
Charlton CG; Crowell B
Mol Chem Neuropathol; 1995 Dec; 26(3):269-84. PubMed ID: 8748929
[TBL] [Abstract][Full Text] [Related]
7. Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.
Bottiglieri T; Arning E; Wasek B; Nunbhakdi-Craig V; Sontag JM; Sontag E
J Neurosci; 2012 Jul; 32(27):9173-81. PubMed ID: 22764226
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.
Charlton CG; Crowell B
Pharmacol Biochem Behav; 1992 Oct; 43(2):423-31. PubMed ID: 1359575
[TBL] [Abstract][Full Text] [Related]
9. Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease.
Müller T; Woitalla D; Hauptmann B; Fowler B; Kuhn W
Neurosci Lett; 2001 Jul; 308(1):54-6. PubMed ID: 11445284
[TBL] [Abstract][Full Text] [Related]
10. Brain ATP:L-methionine S-adenosyltransferase (MAT), S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH): regional distribution and age-related changes.
Trolin CG; Löfberg C; Trolin G; Oreland L
Eur Neuropsychopharmacol; 1994 Dec; 4(4):469-77. PubMed ID: 7894257
[TBL] [Abstract][Full Text] [Related]
11. Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease.
Cheng H; Gomes-Trolin C; Aquilonius SM; Steinberg A; Löfberg C; Ekblom J; Oreland L
Exp Neurol; 1997 Jun; 145(2 Pt 1):580-5. PubMed ID: 9217094
[TBL] [Abstract][Full Text] [Related]
12. Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa.
Charlton CG; Crowell B
Life Sci; 2000 Apr; 66(22):2159-71. PubMed ID: 10834300
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic analysis of S-adenosylmethionine and its metabolites in rat tissues: interrelationship with changes in biogenic catechol levels following treatment with L-dopa.
Wagner J; Danzin C; Huot-Olivier S; Claverie N; Palfreyman MG
J Chromatogr; 1984 May; 290():247-62. PubMed ID: 6736164
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
[TBL] [Abstract][Full Text] [Related]
15. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
16. A new caffeine biosynthetic pathway in tea leaves: utilisation of adenosine released from the S-adenosyl-L-methionine cycle.
Koshiishi C; Kato A; Yama S; Crozier A; Ashihara H
FEBS Lett; 2001 Jun; 499(1-2):50-4. PubMed ID: 11418110
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.
Charlton CG; Mack J
Mol Neurobiol; 1994; 9(1-3):149-61. PubMed ID: 7888091
[TBL] [Abstract][Full Text] [Related]
18. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, reduces the peripheral O-methylation of L-DOPA and enhances its availability to the brain.
Parada A; Soares-da-Silva P
Pharmacology; 2003 May; 68(1):29-37. PubMed ID: 12660477
[TBL] [Abstract][Full Text] [Related]
19. Regiocomplementary O-Methylation of Catechols by Using Three-Enzyme Cascades.
Siegrist J; Aschwanden S; Mordhorst S; Thöny-Meyer L; Richter M; Andexer JN
Chembiochem; 2015 Dec; 16(18):2576-9. PubMed ID: 26437744
[TBL] [Abstract][Full Text] [Related]
20. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
